Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Ingre

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Neurology|May 20, 2023
Diagnostic delay in amyotrophic lateral sclerosisKelly G Gwathmey, Philippe Corcia, Chris J McDermott, et al.
Plos Medicine|September 15, 2022
Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in SwedenJiangwei Sun, Jonas F Ludvigsson, Caroline Ingre, et al.
Neurology|July 14, 2017
Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosisElisa Longinetti, Daniela Mariosa, Henrik Larsson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 27, 2013
No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and IcelandCaroline Ingre, Susana Pinto, Anna Birve, et al.
Journal of Internal Medicine|August 6, 2025
Hospital-treated infections and the risk and prognosis of amyotrophic lateral sclerosis: A population-based studyYihan Hu, Charilaos Chourpiliadis, Caroline Ingre, et al.
JAMA Neurology|January 20, 2026
Long-Term Exposure to Air Pollution and Risk and Prognosis of Motor Neuron DiseaseJing Wu, Andrei Pyko, Charilaos Chourpiliadis, et al.
The Lancet Regional Health. Europe|January 6, 2025
Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case-control studyCharilaos Chourpiliadis, Anikó Lovik, Christina Seitz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 22, 2024
Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosisJennie Olofsson, Sofia Bergström, Sára Mravinacová, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 31, 2023
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)Juliette Foucher, Ivar Winroth, Anikó Lovik, et al.
Brain, Behavior, & Immunity - Health|December 9, 2024
Immune cells and the trajectories of depression, anxiety, and cognitive function among people with amyotrophic lateral sclerosisYihan Hu, Elie Deeba, Ulf Kläppe, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Neurology|May 20, 2023
Diagnostic delay in amyotrophic lateral sclerosisKelly G Gwathmey, Philippe Corcia, Chris J McDermott, et al.
Plos Medicine|September 15, 2022
Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in SwedenJiangwei Sun, Jonas F Ludvigsson, Caroline Ingre, et al.
Neurology|July 14, 2017
Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosisElisa Longinetti, Daniela Mariosa, Henrik Larsson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 27, 2013
No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and IcelandCaroline Ingre, Susana Pinto, Anna Birve, et al.
Journal of Internal Medicine|August 6, 2025
Hospital-treated infections and the risk and prognosis of amyotrophic lateral sclerosis: A population-based studyYihan Hu, Charilaos Chourpiliadis, Caroline Ingre, et al.
JAMA Neurology|January 20, 2026
Long-Term Exposure to Air Pollution and Risk and Prognosis of Motor Neuron DiseaseJing Wu, Andrei Pyko, Charilaos Chourpiliadis, et al.
The Lancet Regional Health. Europe|January 6, 2025
Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case-control studyCharilaos Chourpiliadis, Anikó Lovik, Christina Seitz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 22, 2024
Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosisJennie Olofsson, Sofia Bergström, Sára Mravinacová, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 31, 2023
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)Juliette Foucher, Ivar Winroth, Anikó Lovik, et al.
Brain, Behavior, & Immunity - Health|December 9, 2024
Immune cells and the trajectories of depression, anxiety, and cognitive function among people with amyotrophic lateral sclerosisYihan Hu, Elie Deeba, Ulf Kläppe, et al.
Pageof 9